CP7-FP13-2

N/A

Report date: 2023/12/21 16:06:10
NME

Base Information

Drug NameCP7-FP13-2
Drug Alias NameCP7-FP13-2
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSouthern Medical University, ChinaGuizhou Tongren People's Hospital
China Registration ClassN/A

Develop Information

Active CompaniesGuizhou Tongren People's HospitalSouthern Medical University, China
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A